Navigation Links
Drug Shortages Even Worse This Year: FDA
Date:10/1/2011

By Amanda Gardner
HealthDay Reporter

FRIDAY, Sept. 30 (HealthDay News) -- Prescription drug shortages in the United States, which reached a record high last year, are getting worse, the U.S. Food and Drug Administration said Friday.

So far this year, some 200 drug shortages have occurred compared to 178 in all of 2010, said Valerie Jensen, associate director of the Drug Shortage Program within the FDA's Center for Drug Evaluation and Research.

"This is real," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge, La. "We've been down on this for several years. We have been able to manage around the issue here, but it is a very real issue and a very real problem."

Many of the scarce drugs are injectables, such as cytarabine and cisplatin, used to treat serious conditions such as cancer. Some are only given in hospitals and are "absolutely critical," said Jensen, who spoke at a Friday press conference.

More than half (54 percent) of shortages in 2010 were because of quality issues, such as sterility or drug impurities. Some were due to delays or manufacturing capacity problems, with 11 percent caused by discontinuation of a drug and 5 percent resulting from raw material shortages, Jensen said.

"In 2011, we're seeing the same trend, a very large number of quality product issues leading to shortages," she added.

Shortages also tend to occur in drugs that are not "economically attractive," said Jensen. This could mean that only one company produces the drug, making it harder to find alternatives if the supply dries up.

"A lot of it has to do with generic drugs," Brooks explained. "Few people make them. The margins are not very high."

The anesthetic propofol, which was implicated in Michael Jackson's death, for instance, sells for only 48 cents per 20 milliliter vial. A shortage of propofol in 2010 "was severe," said Jensen.

Some shortages are unforeseeable.

"There were several potential shortages due to the Japan earthquake," Jensen said. Several firms lost suppliers, but the FDA was able to quickly qualify other suppliers and avert any actual shortages, she said.

The FDA has very limited authority to combat shortages, and it cannot tell a company how much of a medication to produce. Although it requires sole producers of a drug to inform the agency if they're going to discontinue it, there is no penalty if firms don't report to the agency.

More information

For more on drug shortages, visit the U. S. Food and Drug Administration.

SOURCES: Jay Brooks, M.D., chairman of hematology/oncology, Ochsner Health System, Baton Rouge, La.; Sept. 30, 2011, teleconference with Valerie Jensen, R.Ph., associate director, Drug Shortage Program, Center for Drug Evaluation and Research, U.S. Food and Drug Administration


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer Drug Shortages Getting Worse, FDA Says
2. Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages
3. Patients underlying health linked to worse outcomes for melanoma, U-M study finds
4. Younger Blacks Fare Worse on Dialysis, Study Finds
5. As Heart Failure Worsens, Word Recall May Suffer Too
6. Breast Cancer Plus Other Health Issues Linked to Worse Outcomes
7. Worse outcomes for older breast cancer patients with other health problems
8. Stress May Worsen Lung Function in Kids Breathing Dirty Air
9. Heightened immunity to colds makes asthma flare-ups worse, U-M research shows
10. Following colorectal cancer surgery, longer delay before chemotherapy associated with worse survival
11. Fear of Dying During Heart Attack May Make Matters Worse
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Shortages Even Worse This Year: FDA
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life ... announced the organization has earned its ISO 13485 certification, indicating the company’s quality ... all rules and policies associated with ISO quality standard 13485. , BSI ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... will be presenting at two upcoming investor conferences: ... 730 Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand ...
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology: